Welcome to the e-CCO Library!

P490: A vedolizumab population pharmacokinetic model including intravenous and subcutaneous formulations for patients with ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Rosario*1, D. Polhamus2, C. Chen1, W. Sun1, N. Dirks2

Created: Friday, 22 February 2019, 9:41 AM
P490: Clinicians’ adherence to European Crohn’s and Colitis Organisation guidelines in the clinical care of adults with inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

B. Jackson*, D. Con, P. De Cruz

Created: Friday, 22 February 2019, 9:49 AM
P490: Drug survival and immunogenicity after switching from Remicade® to biosimilar CT-P13 in inflammatory bowel disease patients: Two-year follow-up of a prospective observational cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Smits1*, L. Derikx1,2, A. van Esch1, J. Drenth1, R. Boshuizen3, D. de Jong1, F. Hoentjen1

Created: Thursday, 21 February 2019, 9:14 AM
P490: Etrasimod for the treatment of ulcerative colitis: up to 2.5 years of pooled safety data from global clinical trials
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Vermeire, S.(1)*;Peyrin-Biroulet, L.(2,3);Panés, J.(4);Regueiro, M.(5);Kotze, P.G.(6);Charabaty, A.(7);Goetsch, M.(8);Shan, K.(9);Wu, J.(10);McDonnell, A.(11);Woolcott, J.(12);Danese, S.(13);
Created: Friday, 14 July 2023, 11:05 AM
P490: Patients with inflammatory bowel disease should be vaccinated against pneumococcus and influenza despite immunosuppressive therapy
Year: 2022
Source: ECCO'22
Authors: Dohos, D.(1);Müller, K.E.(1);Sipos, Z.(2);Kiss, S.(2);Dembrovszky, F.(2);Kovács, N.(2);Solymár, M.(2);Erőss, B.(2);Hegyi, P.(2);Sarlós, P.(3);
Created: Friday, 11 February 2022, 3:56 PM
P490: The impact of the COVID-19 pandemic on gastroenterologists providing care to inflammatory bowel disease patients in Canada: preliminary data of a cross-sectional survey
Year: 2021
Source: ECCO'21 Virtual
Authors: Mikail, M.(1);Malhi, G.(1);Wilson, A.(2);Khanna, R.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P491 De-escalation of dose-intensified anti-TNF therapy in IBD patients in sustained deep remission
Year: 2020
Source:

ECCO'20 Vienna

Authors:

I. Chu1,2, R. Little1,2, M. Sparrow1,2, M. Ward1,2

Created: Thursday, 30 January 2020, 10:12 AM
P491: Comparison of the durability of response to subcutaneous anti-TNF therapy between ulcerative colitis and Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mellotte G.*1,2, McShane C.1,2, O'Connell J.1,2, Mc Kiernan S.1,2, Mac Carthy F.1,2, Kevans D.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P491: Efficacy and safety of upadacitinib for the treatment of fistulas and fissures in patients with Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Colombel, J.F.(1)*;Irving, P.(2);Rieder, F.(3);Panaccione, R.(4);Schwartz, D.(5);Hayashi, R.(6);Zhu, X.(7);Lacerda, A.P.(8);Dubcenco, E.(8);Marced, E.(8);Hecht, P.(8);Feng, T.(8);Berg, S.(8);Reinisch, W.(9);
Created: Friday, 14 July 2023, 11:05 AM
P491: Efficacy and safety outcomes of long-term treatment with filgotinib 200 mg among patients with Ulcerative Colitis: An interim analysis of SELECTIONLTE
Year: 2022
Source: ECCO'22
Authors: FeaganSenior Scientific Officer, B.G.(1,2);Matsuoka, K.(3);Rogler, G.(4);Faes, M.(5);Oortwijn, A.(6);de Haas, A.(6);Rudolph, C.(6);Patel, H.(5);Peyrin-Biroulet, L.(7);
Created: Friday, 11 February 2022, 3:56 PM
P491: In patients with active ulcerative colitis, cytapheresis spares corticosteroids, and reduces hospitalisation time: therapeutic outcomes in 181 consecutive patients.
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. Nomura*, T. Osada, T. Shibuya, D. Ishikawa, K. Haga, N. Sakamoto, S. Watanabe

Created: Friday, 22 February 2019, 9:49 AM
P491: Infectious risk of vedolizumab compared with other biological agents in the treatment of Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Innocenti, T.(1,2);Roselli, J.(1,2);Lynch, E.N.(1,2);Apolito, P.(1,2);Parisio, L.(1,2);Bagnoli, S.(2);Macrì, G.(2);Rogai, F.(2);Milani, S.(1);Galli, A.(1);Milla, M.(2);Dragoni, G.(1,2,3);
Created: Wednesday, 2 June 2021, 4:12 PM
P491: INSPIRE: design and implementation aspects of a registry of complex perianal fistulas in Crohn’s disease patients treated with darvadstrocel
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

O. Zmora*1, J. Panés2, C. Drohan3, J. M. Khalid4, S. Campbell-Hill4, C. Agboton5

Created: Friday, 22 February 2019, 9:41 AM
P492 Use of bowel ultrasound to assess disease activity in Crohn’s disease patients after induction therapy with infliximab
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Frias Gomes1, C. Neto Nascimento1, F. Pereira2, A. Caldeira2, R. Sousa2, C. Arieira3, S. Xavier3, S. Monteiro3, F. Dias de Castro3, S. Leite3, J. Cotter3, A.A. Santos1, M. Cravo1, J. Torres1, C. Palmela1

Created: Thursday, 30 January 2020, 10:12 AM
P492: A comparison of treatment effects for clinical, endoscopic and histological remission in ulcerative colitis clinical trials
Year: 2022
Source: ECCO'22
Authors: Sedano, R.(1);Hogan, M.(2);Zou, G.(3);Narula, N.(4);Singh, S.(5);Ma, C.(6);Jairath, V.(7);
Created: Friday, 11 February 2022, 3:56 PM
P492: Cumulative safety signal review confirmed the established safety profile of Asacol™ (mesalazine)
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Timeus S.*1, Marchi P.2

Created: Wednesday, 20 February 2019, 10:36 AM
P492: Gender differences in patient’s perspectives for impact of inflammatory bowel disease on their life: An Online Korean Association for the Study of Intestinal Disease (KASID) survey
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y.S. Kim1*, G.S. Seo2, S.W. Hwang3, H.J. Yang4, C.H. Tae5, H.J. Lee6, D.-w.L. Lee7, Y.J. Lee8, D.-S. Myung9, J.M. Lee10, Y.T. Jeen11

Created: Thursday, 21 February 2019, 9:14 AM
P492: Influence of the interval of time between the first and the second anti-TNF in the response to treatment in patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Baston*1, N. Mora-Cuadrado2, C. Calviño1, V. Mauriz-Barreiro1, D. De la Iglesia1, J. Gonzalez3, R. Ferreiro-Iglesias1, J. E. Dominguez-Munoz1, M. Barreiro-de Acosta1

Created: Friday, 22 February 2019, 9:41 AM
P492: Perioperative complications have long-term effect on quality of life after restorative proctocolectomy
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. Lee1, A. McCombie*1, 2, R. Vanamala1, R. Gearry3, F. Frizelle1, E. McKay1, J. Williman4, T. Eglinton1

Created: Friday, 22 February 2019, 9:49 AM